Retatrutide: phase III ongoing (expected completion 2026)
Kristina screens for absolute contraindications such as personal or family history of medullary thyroid carcinoma, MEN2, severe gastroparesis, pregnancy, or breastfeeding before starting therapy
The FDA cleared orforglipron for chronic weight management in adults with obesity, or overweight with at least one weight-related comorbidity, based on the ATTAIN clinical program which showed placebo-adjusted weight loss of 7.5% to 11.2% in non-diabetics (ATTAIN-1) and 5.1% to 9.6% in diabetics at different doses, along with the expected glycaemic benefits (ATTAIN-2)
Started Zepbound the second week of February, and as of September 1, have lost 65 lbs and went from a 42 waist to a 34 and never walked into a gym
Those two events converged to make the Canadian generic route the clearest lower-cost option available
JAFRI Medical Director Semaglutide Injection Homekit $125.00 or Original price was: $125.00.$100.00Current price is: $100.00